FAQ/Help |
Calendar |
Search |
Today's Posts |
10-28-2016, 04:54 PM | #1 | ||
|
|||
Member
|
In a study published in the journal Cell Stem Cell, authors say stem cell engineering combined with mesencephalic dopamine grafting is a promising strategy for combating the brain damage associated with Parkinson's disease, and that their new production method brings the treatment closer to clinical use.
"We have identified a specific set of markers that correlate with high dopaminergic yield and graft function after transplantation in animal models of Parkinson's disease," author Agnete Kirkeby said in a press release. "Guided by this information, we have developed a better and more accurate methods for producing dopamine cells for clinical use in a reproducible way." Scientists look to dopamine production in Parkinson's research - UPI.com |
||
Reply With Quote |
"Thanks for this!" says: | anagirl (10-28-2016), eds195 (10-28-2016), lab rat (10-28-2016), Nan Cyclist (10-29-2016), soccertese (10-29-2016) |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Technique Using 3-D Scaffolds Greatly Improves Survival of Stem Cell-Derived Neurons | ALS News & Research | |||
Stem cell-derived dopaminergic neurons rescue motor defects in Parkinsonian monkeys | Parkinson's Disease | |||
A stem cell treatment that looks beyond dopamine | Parkinson's Disease | |||
Dopamine producing neurons from adult stem cells | Parkinson's Disease | |||
Stem cell therapy rescues motor neurons in ALS model | ALS News & Research |